Icecure Medical Q1 EPS $(0.08), Inline, Sales $743.00K Miss $875.50K Estimate
Portfolio Pulse from Benzinga Newsdesk
Icecure Medical (NASDAQ:ICCM) reported Q1 EPS of $(0.08), meeting analyst expectations, but missed sales estimates with $743K, a 4.65% increase from last year.
May 28, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Icecure Medical reported Q1 EPS of $(0.08), meeting analyst expectations, but missed sales estimates with $743K, a 4.65% increase from last year.
While the EPS met expectations, the significant miss on sales estimates by 15.57% is likely to negatively impact the stock price in the short term. The slight year-over-year sales increase is not enough to offset the negative sentiment from missing sales targets.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100